1521 - 1530 of 8823 Results
Title
Year
-
OPENTitle: All that’s fit to preprintJournal Name: Nature BiotechnologyPublisher: Springer Science and Business Media LLCVol: 38Issue #: 5Start Page: 507End Page: 507Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41587-020-0536-xBest OA location URL: https://www.nature.com/articles/s41587-020-0536-x.pdfCitation Count: 11
-
OPENTitle: Anodal tDCS modulates cortical activity and synchronization in Parkinson's disease depending on motor processingJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 22Issue #:Start Page: 101689End Page: 101689Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2019.101689Best OA location URL: https://doi.org/10.1016/j.nicl.2019.101689Citation Count: 30
-
RESTRICTEDTitle: Genetic analysis of neurodegenerative diseases in a pathology cohortJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 76Issue #:Start Page: 214.e1End Page: 214.e9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.11.007Citation Count: 51
-
OPENTitle: Multimodal MRI evaluation of parkinsonian limbic pathologiesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 76Issue #:Start Page: 194End Page: 200Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.01.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6461740Citation Count: 15
-
OPENTitle: 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interactionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 121Issue #:Start Page: 120End Page: 130Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.018Best OA location URL: https://doaj.org/article/19a02c63148348009be80a883732b055Citation Count: 34
-
OPENTitle: Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrilsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 130Issue #:Start Page: 104525End Page: 104525Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104525Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104525Citation Count: 104
- Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition2019OPENTitle: Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competitionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 132Issue #:Start Page: 104577End Page: 104577Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104577Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104577Citation Count: 43
-
OPENTitle: Portrait of blood-derived extracellular vesicles in patients with Parkinson’s diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 124Issue #:Start Page: 163End Page: 175Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.11.002Best OA location URL: https://doaj.org/article/8d8cf4f9837744e3b7e12b8b5fafeecfCitation Count: 50
-
OPENTitle: β-catenin aggregation in models of ALS motor neurons: GSK3β inhibition effect and neuronal differentiationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 130Issue #:Start Page: 104497End Page: 104497Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104497Best OA location URL: https://repositorio.uchile.cl/handle/2250/172258Citation Count: 24
-
RESTRICTEDTitle: Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonismJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 158Issue #:Start Page: 107725End Page: 107725Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2019.107725Citation Count: 39